Prevalence of menstrual irregularities after coronavirus disease 2019 vaccination: A cross-sectional study in the Eastern Province, Saudi Arabia

Autor: Rabia Latif, Deena A. Aldossary, Najla A. Aljabari, Saja S. Alowaied, Latifah A. Aljabari, Noor J. Albash, Aseel S. Alabdulhadi, Nazish Rafique, Lubna I. Al-Asoom, Ayad M. Salem
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Journal of Family and Community Medicine, Vol 31, Iss 1, Pp 71-78 (2024)
Druh dokumentu: article
ISSN: 1319-1683
2229-340X
DOI: 10.4103/jfcm.jfcm_115_23
Popis: BACKGROUND: Reports indicate that there are menstrual cycle disturbances following coronavirus disease 2019 (COVID-19) vaccination. The present study explored the prevalence of menstrual irregularities after COVID-19 vaccination and the association of menstrual irregularities with vaccine type, doses, immediate adverse effects, history of COVID-19 infection, and its severity. MATERIALS AND METHODS: For this cross-sectional study, 406 women of reproductive age completed an online survey about the postvaccine changes in their menstruation (cycle duration, bleeding days, and bleeding amount), COVID-19 vaccine history (doses, type of vaccine, and immediate adverse effects), history of COVID-19 infection, and its severity. Data was analyzed using SPSS; descriptive statistics were computed and Chi-square test, and binary logistic regression analysis were performed. RESULTS: Of the total 406 women, 45% reported postvaccine changes in their menstrual cycle. The most common menstrual change was increased dysmenorrhea (68%), followed by an increase in the length of the cycle (52%). There was a significant association between postvaccine menstrual changes and the age, marital status, and family history of menstrual irregularities. No association was observed between postvaccine menstrual changes and COVID-19 vaccine-and COVID-19 infection-related variables. As per the best-fit model of our predictors, the odds of having postvaccine menstrual changes were 0.41 times less in “single” women (confidence interval [CI] = 0.26–0.27; P < 0.001) and 1.714 times greater in women who had a “family history of menstrual irregularities” (CI = 1.092–2.690; P = 0.02), respectively. CONCLUSION: A substantial number of women complained of postvaccine menstrual changes regardless of their age, type of COVID-19 vaccine, doses, immediate adverse effects, and COVID-19 infection history/severity. Being “single” decreased the probability, whereas having a family history of menstrual irregularities increased the probability significantly of having postvaccine menstrual changes.
Databáze: Directory of Open Access Journals
Externí odkaz: